ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Epigenetics >HDAC inhibitors >Belinostat (PXD101)

Belinostat (PXD101)

Belinostat (PXD101) Structure
CAS No.
414864-00-9
Chemical Name:
Belinostat (PXD101)
Synonyms
Belinostat;PXD101;CS-424;PX105684;NSC726630;belinosta;BelioMstat;BENLINOSTAT;Belinostat-D5;Rac-Belinostat
CBNumber:
CB3260643
Molecular Formula:
C15H14N2O4S
Molecular Weight:
318.35
MOL File:
414864-00-9.mol
MSDS File:
SDS
Modify Date:
2023/5/18 11:31:10

Belinostat (PXD101) Properties

Melting point 142 - 145°C
Density 1.427±0.06 g/cm3(Predicted)
storage temp. Amber Vial, Refrigerator, Under inert atmosphere
solubility DMSO (Slightly), Methanol (Slightly)
form Solid
pka 8.31±0.10(Predicted)
color Off-White to Pale Orange
Stability Light Sensitive

SAFETY

Risk and Safety Statements

HS Code  29350090

Belinostat (PXD101) Chemical Properties,Uses,Production

Description

Belinostat is a drug which was developed by Spectrum Pharmaceuticals and is currently marketed by Onxeo as Beleodaq®. The drug, which received fast track designation by the United States Food and Drug Administration (US FDA) and was approved for the treatment of hematological malignancies and solid tumors associated with peripheral T-cell lymphoma (PTCL) in 2014, is a histone deacetylase (HDAC) inhibitor and is the third such treatment to receive accelerated approval for PTCL, the others being vorinostat (Zolinza®) and pralatrexate (Folotyn®). Although belinostat was not yet approved in Europe as of August 2014, the compound exhibits a safety profile considered to be acceptable for HDAC inhibitors–less than 25% of patients reported adverse effects and these most frequently were nausea, fatigue, pyrexia, anemia, and emesis.

Uses

Belinostat is a novel histone deacetylase 3 selective inhibitor, which protects the β cells from cytokine-induced apoptosis.

Definition

ChEBI: A hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.

Belinostat (PXD101) Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 205)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Biophore India Pharmaceuticals Pvt Ltd +91-9100031592 +91-9030907714 Telangana, India 134 58 Inquiry
FRESENIUS KABI ONCOLOGY LTD +86-571-28971376 New Delhi, India 21 58 Inquiry
MSN LABORATORIES PRIVATE LTD +91 40 30438600 New Delhi, India 230 58 Inquiry
BIOPHORE INDIA PHARMACEUTICALS PVT LTD +91-4047474545 New Delhi, India 105 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
Capot Chemical Co.,Ltd. 571-85586718 +8613336195806 China 29798 60 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32835 60 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29899 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry

Related articles

  • Uses of Belinostat
  • Belinostat is a novel agent that inhibits the enzyme histone deacetylase (HDAC) with a sulfonamide-hydroxamide structure. It w....
  • Oct 21,2019

Belinostat (PXD101) Spectrum

PXD101, Beliomsta BELINOSTAT (PXD101);PXD101 PXD101 N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE N-HYDROXY-3-(3-PHENYLSULFAMOYLPHENYL)ACRYLAMIDE Belinostat Belinostat(PXD101) 2-PropenaMide, N-hydroxy-3-[3-[(phenylaMino)sulfonyl]phenyl]- PX105684 Belinostat-13C6 Belinostat-D5 (E)-N-hydroxy-3-(3-(N-phenylsulfaMoyl)phenyl)acrylaMide PXD101, BelioMstat BelioMstat BENLINOSTAT BelioMstat PXD101 NSC726630 N-Hydroxy-3-(3-phenylsulfamoylphenyl)acrylamide Belinostat Belinostat, 98%, a new type of HDAC inhibitor Belinostat, >=98% N-Hydroxy-3-(3-(N-phenylsulfamoyl)phenyl)acrylamide PXD101;PX105684;PXD-101;PXD 101;PX-105684;NSC726630 Belinostat (PXD101), >98% (2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide CS-424 (E/Z)-Belinostat Belinostat (PXD101) USP/EP/BP Belinostat(Random Configuration) belinosta NSC726630|||PXD101|||PX-105684 Rac-Belinostat 414864-00-9 C15H9N2O4SD5 Inhibitors API Inhibitor